Open AccessOLANZAPINE VERSUS APREPITANT IN PATIENTS RECEIVING HIGH-EMETOGENIC CHEMOTHERAPY: INTERIM ANALYSIS OF RANDOMIZED PHASE II TRIAL
Author(s) -
А. А. Rumyantsev,
Е. В. Глазкова,
R. Yu. Nasyrova,
Ekaterina Ignatova,
Л. В. Читиа,
А. С. Попова,
Х. Х.-М. Эльснукаева,
И. А. Покатаев,
Alexandra Tyulyandina,
М. Б. Стенина,
М. А. Фролова,
A. Bulanov,
V.Yu. Fedyanin,
O. Sekhina,
А. А. Tryakin,
Sergei Tjulandin
Publication year - 2018
Publication title -
praktičeskaâ onkologiâ
Language(s) - English
Resource type - Journals
eISSN - 1726-9830
pISSN - 1726-9814
DOI - 10.31917/1903419
Subject(s) - aprepitant , interim analysis , olanzapine , interim , nk1 receptor antagonist , medicine , randomized controlled trial , chemotherapy , oncology , antiemetic , psychiatry , political science , schizophrenia (object oriented programming) , law , receptor , substance p , neuropeptide